Cellectar Biosciences - 20 Year Stock Price History | CLRB
Historical daily share price chart and data for Cellectar Biosciences since 2005 adjusted for splits and dividends. The latest closing stock price for Cellectar Biosciences as of January 31, 2025 is 0.25.
- The all-time high Cellectar Biosciences stock closing price was 10342800.00 on November 30, 2005.
- The Cellectar Biosciences 52-week high stock price is 4.45, which is 1680% above the current share price.
- The Cellectar Biosciences 52-week low stock price is 0.22, which is 12% below the current share price.
- The average Cellectar Biosciences stock price for the last 52 weeks is 2.35.
| Cellectar Biosciences Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 0.2759 | 0.3249 | 0.3499 | 0.2422 | 0.2514 | -15.92% |
| 2024 | 2.6236 | 2.8600 | 4.2400 | 0.2350 | 0.2990 | -89.21% |
| 2023 | 1.9208 | 1.6300 | 2.9100 | 1.3500 | 2.7700 | 61.99% |
| 2022 | 4.3403 | 7.0990 | 7.8000 | 1.2700 | 1.7100 | -74.25% |
| 2021 | 13.0324 | 20.7000 | 25.0000 | 6.1100 | 6.6400 | -68.08% |
| 2020 | 16.1534 | 24.9000 | 31.7000 | 10.3000 | 20.8000 | -7.56% |
| 2019 | 20.5260 | 15.8000 | 28.5000 | 10.6000 | 22.5000 | 45.16% |
| 2018 | 70.8377 | 137.0000 | 137.0000 | 12.9000 | 15.5000 | -88.69% |
| 2017 | 172.6918 | 128.0000 | 266.0000 | 112.0000 | 137.0000 | 12.30% |
| 2016 | 310.3655 | 732.0000 | 761.5000 | 105.0000 | 122.0000 | -83.40% |
| 2015 | 2506.5952 | 3060.1000 | 3550.0000 | 685.0000 | 735.0000 | -76.21% |
| 2014 | 5525.4690 | 7600.0000 | 8400.0000 | 1989.5000 | 3090.0000 | -58.24% |
| 2013 | 9109.5238 | 14800.0000 | 15800.0000 | 6000.0000 | 7400.0000 | -50.00% |
| 2012 | 19215.2000 | 9000.0000 | 40000.0000 | 8600.0000 | 14800.0000 | 68.18% |
| 2011 | 43157.9365 | 122400.0000 | 153000.0000 | 7400.0000 | 8800.0000 | -90.41% |
| 2010 | 1136328.5714 | 9088200.0000 | 9088200.0000 | 61200.0000 | 91800.0000 | -98.82% |
| 2009 | 2159971.4286 | 1438200.0000 | 7772400.0000 | 1040400.0000 | 7772400.0000 | 440.43% |
| 2008 | 1585878.2609 | 1866600.0000 | 2448000.0000 | 673200.0000 | 1438200.0000 | -21.67% |
| 2007 | 2608558.5657 | 2754000.0000 | 4161600.0000 | 1315800.0000 | 1836000.0000 | -31.82% |
| 2006 | 3745756.9721 | 5814000.0000 | 6915600.0000 | 1927800.0000 | 2692800.0000 | -56.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.010B | $0.000B |
| Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $221.767B | 27.38 |
| Boston Scientific (BSX) | United States | $151.377B | 43.52 |
| Stryker (SYK) | United States | $149.082B | 32.08 |
| EssilorLuxottica (ESLOY) | France | $125.055B | 0.00 |
| Medtronic (MDT) | Ireland | $117.214B | 17.41 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.950B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.139B | 28.03 |
| GE HealthCare Technologies (GEHC) | United States | $40.136B | 20.82 |
| ResMed (RMD) | United States | $37.119B | 30.50 |
| Terumo (TRUMY) | Japan | $28.886B | 41.07 |
| Koninklijke Philips (PHG) | Netherlands | $25.642B | 19.63 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.107B | 14.07 |
| Insulet (PODD) | United States | $19.438B | 77.40 |
| Baxter (BAX) | United States | $16.737B | 10.89 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.065B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.084B | 40.57 |
| Sunny Optical Technology (SNPTF) | China | $9.976B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.966B | 33.87 |
| Demant (WILYY) | Denmark | $8.735B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.433B | 14.95 |
| ICU Medical (ICUI) | United States | $4.121B | 39.23 |
| Prestige Consumer Healthcare (PBH) | United States | $3.893B | 19.36 |
| Envista Holdings (NVST) | United States | $3.678B | 27.40 |
| Haemonetics (HAE) | United States | $3.430B | 16.74 |
| Perrigo (PRGO) | Ireland | $3.366B | 9.91 |
| GN Store Nord (GNNDY) | Denmark | $3.027B | 19.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.927B | 18.84 |
| Neogen (NEOG) | United States | $2.495B | 28.75 |
| LeMaitre Vascular (LMAT) | United States | $2.247B | 54.60 |
| AtriCure (ATRC) | United States | $2.067B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.464B | 25.63 |
| InMode (INMD) | Israel | $1.462B | 8.79 |
| AdaptHealth (AHCO) | United States | $1.430B | 10.22 |
| BioLife Solutions (BLFS) | United States | $1.313B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.270B | 0.00 |
| Owens & Minor (OMI) | United States | $1.150B | 8.99 |
| Evolus (EOLS) | United States | $0.922B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.887B | 15.64 |
| CeriBell (CBLL) | United States | $0.833B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.830B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.649B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.561B | 24.73 |
| Surmodics (SRDX) | United States | $0.511B | 0.00 |
| Omeros (OMER) | United States | $0.502B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.429B | 0.00 |
| Valneva SE (VALN) | France | $0.412B | 0.00 |
| ZimVie (ZIMV) | United States | $0.401B | 33.77 |
| Quanterix (QTRX) | United States | $0.370B | 0.00 |
| Cerus (CERS) | United States | $0.360B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.322B | 30.67 |
| Sanara MedTech (SMTI) | United States | $0.317B | 0.00 |
| Biote (BTMD) | United States | $0.309B | 6.76 |
| OraSure Technologies (OSUR) | United States | $0.291B | 19.50 |
| Canopy Growth (CGC) | Canada | $0.265B | 0.00 |
| Zynex (ZYXI) | United States | $0.263B | 55.13 |
| High Tide (HITI) | Canada | $0.239B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.233B | 3.28 |
| Utah Medical Products (UTMD) | United States | $0.208B | 15.52 |
| Aurora Cannabis (ACB) | Canada | $0.203B | 0.00 |
| Brainsway (BWAY) | Israel | $0.197B | 104.70 |
| MacroGenics (MGNX) | United States | $0.190B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.189B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.154B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 18.27 |
| Quipt Home Medical (QIPT) | United States | $0.135B | 0.00 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| Fonar (FONR) | United States | $0.102B | 11.54 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| InterCure (INCR) | Israel | $0.077B | 0.00 |
| Exagen (XGN) | United States | $0.072B | 0.00 |
| INLIF (INLF) | $0.071B | 0.00 | |
| Rockwell Medical (RMTI) | United States | $0.066B | 34.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Modular Medical (MODD) | United States | $0.051B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.050B | 14.35 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.018B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |